AKT1 and neoplasm: Its role in metabolic reprogramming, particularly via phosphorylation‐induced cytoplasmic retention of ME2 and assembly of glycolytic enzyme complexes, represents a novel and critical mechanism by which Akt1 supports the bioenergetic demands of tumor cells [10].